RNA-based Therapeutics Market Size, Share & Trends Analysis Report By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, RNA Aptamer, Other Therapeutics), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Oncology, Ophthalmology, Hematological Disorders, Acute Hepatic Porphyria (AHP), Others), By End User (Hospitals and Clinics, Research Settings), By Region, And By Segment Forecasts, 2025-2034

Explore our pricing plans

Single User License

$4456
  • PDF Report and Excel Datasheet
  • Delivered in 24-72 hrs. of purchase
  • Access for one individual only
  • Analyst support up to 3 Months
Purchase Now

Multi-User License

$7786
  • PDF Report, Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Access for 5-6 individuals only
  • Analyst support up to 3 Months
Purchase Now

Corporate License

$10000
  • PDF Report, Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Unlimited access for all employees within the organization
  • Analyst support up to 6 Months
Purchase Now

Quantitative Data Access

$1200
  • PowerBI/Excel Pivot Dashboard
  • Excel Datasheet and Power BI
  • Delivered in 24-72 hrs. of purchase
  • Unlimited access for all employees within the organization
  • Analyst support up to 6 Months
Purchase Now